Multiply Labs develops robotic systems for the manufacture of precision medicines. The company's core offering is modular robotic clusters - systems of multiple collaborative robot arms that work in parallel to produce personalized pharmaceutical capsules and cell therapies. This approach targets the life science and pharmaceutical manufacturing sectors, where scaling production of individualized treatments presents significant cost and throughput challenges.
The company's technology sits at the intersection of robotics, artificial intelligence, and automation, applied specifically to cell therapy manufacturing. According to the company, its systems can reduce manufacturing costs by 74% while substantially increasing production throughput. This positions Multiply Labs within a growing niche: the automation of advanced therapeutic manufacturing, an area where traditional production methods have struggled to achieve economies of scale.
